Literature DB >> 10501289

Changes in immune function following surgery for esophageal carcinoma.

T Tashiro1, H Yamamori, K Takagi, N Hayashi, K Furukawa, H Nitta, Y Toyoda, W Sano, T Itabashi, K Nishiya, J Hirano, N Nakajima.   

Abstract

Changes in immune function due to surgical injury have been well-documented. Immunosuppression is one of the causes of infectious complications leading to organ dysfunction in critical illness. It is not known what kind of surgery in the daily clinical practice causes immunosuppression. Stress response and immune function following surgery for esophageal carcinoma, assuming a highly-stressed operation, were studied and then compared with the stress response and immune function following gastric surgery, a moderately-stressed procedure. Forty patients who underwent esophagectomy and 39 patients receiving gastric operation were studied. The concentrations of serum interleukin-6 (IL-6) were measured preoperatively, at 1, 2, and 6 h, and at 1, 3, and 10 d after operation. Total protein, serum albumin, rapid turnover protein, serum CRP, and cortisol were measured before operation and at 1, 3, 7, and 21 d after operation. ConA- and PHA-stimulated lymphocyte proliferation, IgA, IgG, and IgM were also measured preoperatively, and on 7 and 21 d following surgery. The patients were fed exclusively by total parenteral nutrition (TPN). A striking rise of IL-6 was observed, with a peak in both groups at 1 to 6 h following operation. The peak values were 419+/-30 pg/mL, which was approximately twice as high in the esophagectomy patients as in the gastrectomy patients (195+/-40 pg/mL). CRP and cortisol also increased after operation, and these increases were also significantly greater in the esophagectomy patients. ConA- and PHA-stimulated lymphocyte proliferation decreased significantly 7 d after esophagectomy (P<0.05), but was unchanged in the patients receiving gastrectomy. Suppression of cellular immunity correlated significantly with serum cortisol, and was preceded by a rise in serum IL-6. The IgA, IgG, and IgM levels, however, remained unchanged from their preoperative values throughout the study in both groups. Nutritional status in terms of serum protein, albumin, and rapid turnover protein, decreased postoperatively, but there was no difference between the two groups. It is, therefore, concluded that cell-mediated immunosuppression, preceded by a hyperinflammatory response, is an observable reaction in patients following esophageal surgery, but not in patients undergoing gastric surgery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501289     DOI: 10.1016/s0899-9007(99)00151-3

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  9 in total

1.  Effect of traditional chinese medicine on survival and quality of life in patients with esophageal carcinoma after esophagectomy.

Authors:  Ping Lu; Qiu-dong Liang; Rong Li; Hong-rui Niu; Xiao-ge Kou; Hong-jun Xi
Journal:  Chin J Integr Med       Date:  2006-09       Impact factor: 1.978

2.  Reduced perioperative immune response in video-assisted versus open surgery in a rat model.

Authors:  Yoshitaka Ito; Makoto Oda; Yoshio Tsunezuka; Isao Matsumoto; Norihiko Ishikawa; Kazuyuki Kawakami; Yasuhiko Ota; Go Watanabe
Journal:  Surg Today       Date:  2009-07-29       Impact factor: 2.549

3.  Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.

Authors:  Aaron J Schueneman; Elizabeth A Sugar; Jennifer Uram; Elaine Bigelow; Joseph M Herman; Barish H Edil; Elizabeth M Jaffee; Lei Zheng; Daniel A Laheru
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

4.  Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer.

Authors:  Johanna W van Sandick; Suzanne S Gisbertz; Ineke J M ten Berge; Marja A Boermeester; Tineke C T M van der Pouw Kraan; Theo A Out; Hugo Obertop; J Jan B van Lanschot
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

5.  Early postoperative hyperglycaemia is not a risk factor for infectious complications and prolonged in-hospital stay in patients undergoing oesophagectomy: a retrospective analysis of a prospective trial.

Authors:  Titia M Vriesendorp; J Hans DeVries; Jan B F Hulscher; Frits Holleman; Jan J van Lanschot; Joost B L Hoekstra
Journal:  Crit Care       Date:  2004-10-18       Impact factor: 9.097

6.  Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction.

Authors:  Joyce Faber; Madeleen J Uitdehaag; Manon Spaander; Sabine van Steenbergen-Langeveld; Paul Vos; Marloes Berkhout; Cor Lamers; Hans Rümke; Hugo Tilanus; Peter Siersema; Ardy van Helvoort; Ate van der Gaast
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-03-31       Impact factor: 12.910

Review 7.  Immunosuppression following surgical and traumatic injury.

Authors:  Fumio Kimura; Hiroaki Shimizu; Hiroyuki Yoshidome; Masayuki Ohtsuka; Masaru Miyazaki
Journal:  Surg Today       Date:  2010-08-26       Impact factor: 2.549

8.  Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factor.

Authors:  M K Whitworth; A Sheen; D D Rosa; S E Duff; D Ryder; A Burumdayal; K Wiener; R E Hawkins; M Saunders; J W Valle; D Sherlock; G C Jayson
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-26       Impact factor: 4.553

9.  Effects of lipid emulsions in parenteral nutrition of esophageal cancer surgical patients receiving enteral nutrition: a comparative analysis.

Authors:  Wu-Ping Wang; Xiao-Long Yan; Yun-Feng Ni; Kang Guo; Chang-Kang Ke; Qing-Shu Cheng; Qiang Lu; Lan-Jun Zhang; Xiao-Fei Li
Journal:  Nutrients       Date:  2013-12-27       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.